Maria Cecília Ramiro Talarico

4PUBLICATIONS
17CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 29, 2024
Metabolomic Profiling of Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy for Predicting Disease-Free and Overall Survival.

Maria Cecília Ramiro Talarico, Sophie Derchain, Lucas Ferreira da Silva

|Jul 13, 2024
Plasma Metabolome Signatures to Predict Responsiveness to Neoadjuvant Chemotherapy in Breast Cancer.

Alex Ap Rosini Silva, Marcella R Cardoso, Danilo Cardoso de Oliveira

|Oct 27, 2022
Metabolomics by NMR Combined with Machine Learning to Predict Neoadjuvant Chemotherapy Response for Breast Cancer.

Marcella R Cardoso, Alex Ap Rosini Silva, Maria Cecília R Talarico

|Jun 02, 2021
High Expression of SOD2 Protein Is a Strong Prognostic Factor for Stage IIIB Squamous Cell Cervical Carcinoma.

Maria Cecília Ramiro Talarico, Rafaella Almeida Lima Nunes, Gabriela Ávila Fernandes Silva

Pageof 1